Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Sackstein, M.D.,Ph.D.

Concepts

This page shows the publications Robert Sackstein has written about Antibodies, Monoclonal.
Connection Strength

0.087
  1. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med. 2008 Feb; 14(2):181-7.
    View in: PubMed
    Score: 0.026
  2. differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. J Biol Chem. 2001 Dec 14; 276(50):47623-31.
    View in: PubMed
    Score: 0.017
  3. A hematopoietic cell L-selectin ligand exhibits sulfate-independent binding activity. Blood. 1997 Apr 15; 89(8):2773-81.
    View in: PubMed
    Score: 0.012
  4. Expression of an L-selectin ligand on hematopoietic progenitor cells. Acta Haematol. 1997; 97(1-2):22-8.
    View in: PubMed
    Score: 0.012
  5. Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction. J Invest Dermatol. 1988 Nov; 91(5):423-8.
    View in: PubMed
    Score: 0.007
  6. CD43 is a ligand for E-selectin on CLA+ human T cells. Blood. 2006 Feb 15; 107(4):1421-6.
    View in: PubMed
    Score: 0.006
  7. Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation. Transplantation. 2001 Jun 15; 71(11):1601-9.
    View in: PubMed
    Score: 0.004
  8. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation. 2000 Jun 15; 69(11):2296-304.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.